King's College London

Research portal

Development of stem cell therapies for retinal degeneration

Research output: Contribution to journalArticlepeer-review

Emma L. West, Joana Ribeiro, Robin R. Ali

Original languageEnglish
Article numbera035683
Pages (from-to)1-23
Number of pages23
JournalCold Spring Harbor Perspectives In Biology
Issue number8
PublishedAug 2020

Bibliographical note

Publisher Copyright: © 2020 Cold Spring Harbor Laboratory Press; all rights reserved;. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

King's Authors


Degenerative retinal disease is the major cause of sight loss in the developed world and currently there is a lack of effective treatments. As the loss of vision is directly the result of the loss of retinal cells, effective cell replacement through stem-cell-based therapies may have the potential to treat a great number of retinal diseases whatever their underlying etiology. The eye is an ideal organ to develop cell therapies as it is immune privileged, and modern surgical techniques enable precise delivery of cells to the retina. Furthermore, a range of noninvasive diagnostic tests and high-resolution imaging techniques facilitate the evaluation of any therapeutic intervention. In this review, we evaluate the progress to date of current cell therapy strategies for retinal repair, focusing on transplantation of pluripotent stem-cell-derived retinal pigment epithelium (RPE) and photoreceptor cells.

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454